Adherence to HIV antiretroviral therapy in HIV+ Ugandan patients purchasing therapy

International Journal of STD and AIDS

Volumn 16, Issue 1, 2005, Pages 38-41

  Byakika Tusiime, Jayne ^a,b,e   Oyugi, J H ^b,c   Tumwikirize, W A ^a   Katabira, E T ^a,b   Mugyenyi, P N ^d   Bangsberg, D R ^b,c  

^a MAKERERE UNIVERSITY MEDICAL SCHOOL   (Uganda)

^b Academic Alliance for AIDS Care and Prevention in Africa   (Uganda)

^c SAN FRANCISCO GENERAL HOSPITAL   (United States)

^d JOINT CLINICAL RESEARCH CENTRE   (Uganda)

^e NONE   (Uganda)

Author keywords

Adherence; Antiretroviral therapy; Self purchasing; Sub Saharan Africa

Indexed keywords

ABACAVIR; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; DELAVIRDINE; DIDANOSINE; EFAVIRENZ; INDINAVIR; LAMIVUDINE; LOPINAVIR; NELFINAVIR; NEVIRAPINE; PROTEINASE INHIBITOR; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; SAQUINAVIR; STAVUDINE; ZIDOVUDINE;

ADULT; AGED; ARTICLE; DRUG COST; DRUG USE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCOME; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PATIENT COMPLIANCE; PRIORITY JOURNAL; UGANDA;

ADULT; AGED; ANTI-HIV AGENTS; CROSS-SECTIONAL STUDIES; DRUG THERAPY, COMBINATION; FEMALE; HIV INFECTIONS; HUMANS; INTERVIEWS; LOGISTIC MODELS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; REVERSE TRANSCRIPTASE INHIBITORS; UGANDA;

EID: 13244263044     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/0956462052932548     Document Type: Article

References (17)

1. UNAIDS. Report on the Global HIV/AIDS Epidemic. Geneva: UNAIDS, 2000
2. UNAIDS. Report on the Global HIV/AIDS Epidemic. Geneva: UNAIDS, 2002
3. Harries AD, Nyangalu DS, Hargreaves NJ, et al. Preventing antiretroviral anarchy in sub-Saharan Africa. Lancet 2001;358:410-4
4. Laurence J. The cost effectiveness of antiretroviral therapy for HIV disease. N Engl J Med 2001;345:68 (discussion 68-9) 9
5. Little SJ, Routy JP, Daar ES, et al. Antiretroviral Drug Susceptibility and Response to Initial Therapy Among Recently HIV-infected Subjects in North America. Eighth Conference on Retroviruses and Opportunistic Infections. Chicago, 2001
6. Popp D, Fisher JD. First, do no harm: a call for emphasizing adherence and HIV prevention interventions in active antiretroviral therapy programs in the developing world. AIDS 2002;16:676-8
7. Brigido LF, Rodrigues R, Casseb J, et al. Impact of adherence to antiretroviral therapy in HIV-1-infected patients at a university public service in Brazil. AIDS Patient Care STDS 2001;15:587-93
8. Laurent C, Diakhate N, Gueye NF, et al. The Senegalese government's highly active antiretroviral therapy initiative: an 18-month follow-up study. AIDS 2002;16:1363-70
9. Orrell C, Bangsberg DR, Badri M, et al. Adherence is not a barrier to successful antiretroviral therapy in South Africa. AIDS 2003;17:1369-75
10. Mcdowell I, Newell C. Measuring Health: A Guide to Rating Scales and Questionnaires. 2nd edn. New York: Oxford University Press, 1996
11. Haubrich RH, Little SJ, Currier JS, et al. The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response California Collaborative Treatment Group. AIDS 1999;13:1099-107
12. Gifford AL, Bormann JE, Shively MJ, et al. Predictors of self-reported adherence and plasma HIV concentrations in patients on multidrug antiretroviral regimens (in process citation). J Acquir Immune Defic Syndr 2000;23:386-95
13. Chesney MA, Ickovicks JR, Chambers DB, et al. Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG). AIDS Care 2000;12:255-66
14. Arnsten JH, Demas PA, Farzadegan H, et al. Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: comparison of self-report and electronic monitoring. Clin Infect Dis 2001;33:1417-23
15. Nieuwkerk PT, Sprangers MA, Burger DM, et al. Limited patient adherence to highly active antiretroviral therapy for HIV-1 infection in an observational cohort study. Arch Intern Med 2001;161:1962-8
16. Stone VE. Enhancing adherence to antiretrovirais: strategies and regimens. Med Gen Med 2002;4:22
17. Bangsberg DR, Hecht FM, Charlebois ED, et al. Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS 2000;14:357-66